COLUMBIA, Md., Feb. 6, 2017 /PRNewswire/ -- Steep Hill Maryland, operated as an official licensee of Steep Hill, which is headquartered in Berkeley, CA and recognized as the global leader in cannabis testing and analytics, today announced that it is the first Independent Testing Laboratory (ITL) to receive pre-approval from the Maryland Medical Cannabis Commission (MMCC) to test medical cannabis.
Steep Hill Maryland's CEO, Andrew Rosenstein, MD, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area said, "We have been working with state officials to ensure that our independent lab meets or exceeds all of the MMCC lab requirements. We are prepared to operate in full compliance with MMCC criteria, and our goal is to utilize Steep Hill's well-established, highly-regarded analytical and testing services to ensure that Maryland's supply of medical cannabis meets the stringent safety guidelines that the MMCC has put in place to protect patients. Testing in this manner is a natural extension of what we do every day as physicians."
More information about cannabis testing in Maryland, please visit our website: http://steephill.com/maryland.
ABOUT STEEP HILL MARYLAND
Green Analytics MD, LLC d/b/a Steep Hill Maryland, and its sister operations Steep Hill Pennsylvania and Steep Hill D.C., are operated as official licensees of Steep Hill. Steep Hill Maryland/Pennsylvania/D.C. is run by Dr. Andrew Rosenstein, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area, with a complimentary team of board-certified healthcare professionals.
ABOUT STEEP HILL
Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics. Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California—the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™, GenKit™, Steep Hill Express™ and genetic marker and DNA identification. Steep Hill is expanding throughout the U.S. and internationally, and the company provides expert consulting services to many states, countries and municipalities around the world.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/steep-hill-maryland-is-the-first-commercial-cannabis-test-lab-to-receive-pre-approval-to-operate-from-the-state-of-maryland-300402467.html
SOURCE Steep Hill Labs, Inc.